TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis
MediciNova Announces MN-166 (ibudilast) Demonstrated a 26% Reduction in Confirmed Disability Progression
pharmaceutical investing Adamas Announces Publication of ADS-5102 Phase 2 Clinical Trial Results in Multiple Sclerosis Journal
pharmaceutical investing Corbus Gets Patent Covering Use of Anabasum for the Treatment of Rare Fibrotic Diseases
pharmaceutical investing Adamas to Present New ADS-5102 Data from Phase 2 Trial in Walking Impairment Associated with Multiple Sclerosis
QIMC Announces Thermogenic Wet-Gas Signature in 86% of Soil-Gas Samples at New Salem-Apple River, Nova Scotia, Next to Its 30% Clean Hydrogen Discovery
Standard Uranium Initiates Partner Funded Surface Exploration Program at the Corvo Uranium Project, Eastern Athabasca Basin, Saskatchewan
Brixton Metals Drills 4 m of 1,975 g/t Silver within 23.50 m of 348 g/t Silver in Hole 449 at its Langis Project in Ontario
